Merck Sharp & Dohme LLC. v. Prinston Pharmaceutical Inc.
Plaintiff: Merck Sharp & Dohme LLC.
Defendant: Prinston Pharmaceutical Inc.
Case Number: 1:2022cv01300
Filed: October 3, 2022
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on October 27, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
October 27, 2022 Filing 8 STIPULATION TO EXTEND TIME Prinston to Answer the Complaint to December 5, 2022 - filed by Prinston Pharmaceutical Inc.. (Gattuso, Dominick)
October 27, 2022 Opinion or Order SO ORDERED, re (D.I. 8 in 22-cv-1300-RGA; D.I. 686 in 19-md-2902-RGA) STIPULATION and Order to Extend Time to Answer the Complaint to December 5, 2022. Signed by Judge Richard G. Andrews on 10/27/2022. Associated Cases: 1:19-md-02902-RGA, 1:22-cv-01300-RGA(nms)
October 11, 2022 Filing 7 SUMMONS Returned Executed by Merck Sharp & Dohme LLC..Prinston Pharmaceutical Inc. served on 10/7/2022, answer due 10/28/2022. (Joyce, Alexandra)
October 5, 2022 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
October 3, 2022 Filing 6 Summons Issued as to Prinston Pharmaceutical Inc. on 10/3/2022. (vfm)
October 3, 2022 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC. filed by Merck Sharp & Dohme LLC.. (vfm)
October 3, 2022 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (vfm)
October 3, 2022 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/19/2022. Date of Expiration of Patent: 11/24/2026 (May 24, 2027 pediatric exclusivity expiration).Thirty Month Stay Deadline: 2/19/2025. (vfm)
October 3, 2022 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm)
October 3, 2022 Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Prinston Pharmaceutical Inc. ( Filing fee $ 402, receipt number ADEDC-3973283.) - filed by Merck Sharp & Dohme LLC.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Merck Sharp & Dohme LLC. v. Prinston Pharmaceutical Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Merck Sharp & Dohme LLC.
Represented By: Daniel M. Silver
Represented By: Alexandra M. Joyce
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Prinston Pharmaceutical Inc.
Represented By: Dominick T. Gattuso
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?